BioCryst Pharma News, BioCryst Pharma Quote, BCRX Quote

BioCryst Pharma (NQ:BCRX) Delayed: 8.70 +0.27 (3.20%)

Prev. Close

$8.43

Today 6M 1Y 5Y

Open

$8.54

52 Wk High

$10.98

52 Wk Low

$1.63

Day High

$8.73

Day Low

$8.43

P/E

N/A

EPS

$-0.68

Volume

5,219,455

Friends, Peers and Foes (?): ATXS, ACAD, DYN, XENE, CDTX (more...)

ALERTS | RSS

Sep 10, 2026 05:11 AM RBC Capital Downgrades BioCryst Pharma (BCRX) to Sector Perform
Sep 8, 2026 10:26 AM TD Cowen Starts BioCryst Pharma (BCRX) at Buy
Aug 25, 2026 07:02 AM Japan approves BioCryst's Orladeyo for children ages 2 to 12 with HAE
Aug 25, 2026 07:01 AM BioCryst Announces Approval of ORLADEYO® for Pediatric HAE Patients in Japan
Aug 14, 2026 04:48 PM Form SCHEDULE 13G/A BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, L.P.
Aug 7, 2026 08:56 AM Form SCHEDULE 13G BIOCRYST PHARMACEUTICALS Filed by: STATE STREET CORP
Aug 6, 2026 06:43 AM BioCryst Pharma (BCRX) PT Lowered to $13 at RBC Capital
Aug 5, 2026 04:25 PM Form S-8 BIOCRYST PHARMACEUTICALS
Aug 5, 2026 04:05 PM Form 10-Q BIOCRYST PHARMACEUTICALS For: Jun 30
Aug 5, 2026 12:40 PM BioCryst Pharma (BCRX) PT Lowered to $20 at Wedbush

Entities mentioned with BCRX

View All Entities